Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 68 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Sarafidis, Pantelis [Clear All Filters]
Fractioned urine collections to assess urine supersaturation in urolithiasis; a pathway worth exploring..
Urolithiasis. 48(5), 465-466.
(2020). Hypertension Management in Patients With Autosomal Dominant Polycystic Kidney Disease: Time for a Paradigm Shift?.
Am J Kidney Dis. 76(5), 743.
(2020). Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study..
J Nephrol. 33(3), 583-590.
(2020). Lipoprotein(a) Reduction in Persons with Cardiovascular Disease..
N Engl J Med. 382(21), e65.
(2020). Longer Dialysis Sessions Improve Cardiac Systolic Function by Reducing Myocardial Stunning..
J Card Fail. 26(11), 1026-1027.
(2020). Lung Ultrasound-Guided Dry Weight Assessment and Echocardiographic Measures in Hypertensive Hemodialysis Patients: A Randomized Controlled Study..
Am J Kidney Dis. 75(1), 11-20.
(2020).
(2020). Microcirculatory function deteriorates with advancing stages of chronic kidney disease independently of arterial stiffness and atherosclerosis..
Hypertens Res.
(2020). Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney disease..
Expert Opin Pharmacother. 21(10), 1201-1217.
(2020). The presence of diabetes mellitus further impairs structural and functional capillary density in patients with chronic kidney disease..
Microcirculation. e12665.
(2020). Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review..
BMC Nephrol. 21(1), 276.
(2020). SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA..
Nephrol Dial Transplant. 35(10), 1825.
(2020).
(2020). SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia..
Clin Kidney J. 13(5), 728-733.
(2020). SGLT-2 Inhibitors to Treat Hyponatremia Associated with SIADH: A Novel Indication?.
Am J Nephrol. 51(7), 553-555.
(2020). TNF-α pathway and T-cell immunity are activated early during the development of diabetic nephropathy in Type II Diabetes Mellitus..
Clin Immunol. 215, 108423.
(2020). Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study..
J Hypertens. 38(9), 1849-1856.
(2020). Dapagliflozin Does Not Affect Short-Term Blood Pressure Variability in Patients With Type 2 Diabetes Mellitus..
Am J Hypertens. 34(4), 404-413.
(2021).